News Major shareholder announcement – BlackRock, Inc. Staff September 11, 2023 Continue Reading Previous Invivyd Announces Dosing of First Participant in CANOPY Phase 3 Pivotal Clinical Trial Investigating VYD222 for the Prevention of Symptomatic COVID-19 Next Scinai Immunotherapeutics Ltd. to participate this week in H.C. Wainwright 25th Annual Global Investment Conference in New York and LSX USA Congress 2023 in Boston More Stories Healthcare Neurology Neuroscience News Patient Care Pharmaceutical Evotec Announces Progress in Neuroscience Collaboration with Bristol Myers Squibb Staff June 12, 2024 Healthcare News Olympus and HCLTech expand Engineering and R&D partnership Staff June 12, 2024 News Northrim Horizon Completes Acquisition of Noble Hospice Staff June 12, 2024
